Related Experiment Video
Updated: Jun 19, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Regulatory compliance for point-of-care testing: 2009 United States perspective
Sharon S Ehrmeyer1, Ronald H Laessig
1Clinical Laboratory Science/Medical Technology Program, Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA. ehrmeyer@wisc.edu
Abstract:
All clinical laboratory testing in the United States is regulated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA'88 or CLIA) and overseen by the Centers for Medicare and Medicaid Services. CLIA profoundly changed the prevailing United States regulatory philosophy by imposing uniform requirements for all clinical laboratory testing regardless of where tests are performed. In the hospital, regulatory compliance is usually ensured by regular inspections of the laboratory by either the Joint Commission or by the College of American Pathologists. These organizations may include requirements beyond the minimum standard mandated by CLIA. This article reviews the status of regulatory compliance of point-of-care testing from a perspective of the current regulations in effect in the United States in 2009.
Related Concept Videos
Legal Guidelines for Documentation
Drug Regulation
Standards of Care II
Standards of Care I
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drug Control Governance: Regulatory Bodies and Their Impact

